secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-326969
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta exchanges $291.4M of 1.25% notes for 4.875% notes due 2030 plus $31.6M cash
--------------------------------------------------------------------------------

- Exchanged ~$291.4M of existing 1.25% Convertible Senior Notes due 2027 for new 4.875% Convertible Notes due 2030 plus ~$31.6M cash.
- New notes issued as additional notes under August 2025 indenture; total 4.875% notes now ~$893.4M outstanding.
- Exchange involved holders including entity affiliated with board member Michael Chambers.
- Transaction closed December 18, 2025; extends maturity from 2027 to 2030 at higher coupon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/0001193125-25-326969-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312525326969/d32354d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-326969

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer